Stefanova, Nadia http://orcid.org/0000-0001-8188-639X
Wenning, Gregor K.
Article History
Accepted: 22 March 2023
First Online: 21 April 2023
Competing interests
: N.S. reports consultancy fees from Inhibikase Therapeutics and Astellas Pharma and research grants from the Austrian Science Fund (FWF), Alterity Therapeutics and the US MSA Coalition. G.K.W. reports consultancy and lecture fees from Biohaven, Inhibikase, Ono and Takeda and research grants from the Austrian Science Fund (FWF), the Austrian National Bank, the US MSA Coalition, Parkinson Funds Austria and International Parkinson and Movement Disorder Society outside the submitted work.